It is 2009 and CSL begins human trials of the ‘swine flu’ influenza pandemic vaccine in Adelaide, South Australia. Our Parkville, Melbourne facility went on to manufacture millions of doses, helping Australia roll out one of the world’s first swine flu \(H1N1\) vaccination programs. CSL Seqirus is committed to pandemic preparedness and response and is a proud partner to over 30 governments worldwide. Learn more about how we continue to help governments prepare for future influenza pandemics: https://bit.ly/46c1PRh #CSL #CSLSeqirus #PublicHealth #Vaccines #InfluenzaPandemic
Are You Looking for a Meaningful Career?
CSL is a global biotech leader with a diverse collective of dedicated people exploring every avenue, every day, to achieve one shared goal—to reimagine and reinvent new and more effective ways to save, improve and protect life.
Pictured: CSL employee in Melbourne, Australia
We will announce our 2024 Full Year Financial Results on Tuesday, 13th August 2024 (AEST). Click here to read more →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL BehringCSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL SeqirusCSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia